If you’ve been watching infomercials or flipping through a magazine lately, you may think testosterone could be a cure-all. The “low T” movement, also known as “andropause,” targets aging men for their declining testosterone levels. And over the past decade, it’s become a multibillion-dollar industry. Abraham Morgentaler, associate professor of surgery at Beth Israel Deaconess Medical Center, is quoted.

Read the full article